Immunocore Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	452.68	467.71	455.73	442.63	402.47	321.62
Short-Term Investments	392.22	396.44	364.65	-	-	-
Cash & Short-Term Investments	844.9	864.15	820.38	442.63	402.47	321.62
Cash Growth	0.94%	5.34%	85.34%	9.98%	25.14%	81.35%
Accounts Receivable	81.07	73.98	63.01	52.09	33.58	20.56
Other Receivables	-	1.82	-	-	-	13.02
Total Trade Receivables	81.07	75.79	63.01	52.09	33.58	33.58
Inventory	8.25	6.74	5.45	4.5	0.69	-
Other Current Assets	69.59	50.06	41.03	29.6	37.23	-
Total Current Assets	1,004	996.74	929.86	528.82	473.98	355.2
Net Property, Plant & Equipment	49.67	50.25	47.74	42.74	38.78	42.64
Other Long-Term Assets	18.61	20.28	31.91	25.45	14.01	10.15
Total Assets	1,072	1,067	1,010	597	526.76	408
Accounts Payable	30.16	24.36	25.1	17.8	14.45	-
Accrued Expenses	207.39	219.74	185.53	119.84	76.75	-
Current Portion of Leases	2	2.01	1.55	1.39	1.88	1.7
Unearned Revenue	0.57	0.58	-	-	7.76	33.06
Total Current Liabilities	240.11	246.7	212.18	139.02	100.84	34.75
Long-Term Debt	393.66	393.13	391.01	48.01	47.81	50.33
Long-Term Leases	40.03	41.56	40.16	35.61	31.76	34.28
Other Long-Term Liabilities	4.62	4.86	5.43	5.52	7.46	8.66
Total Long-Term Liabilities	438.31	439.54	436.61	89.14	87.02	93.27
Total Liabilities	678.42	686.24	648.79	228.16	187.86	176.07
Common Stock	0.14	0.14	0.14	0.14	0.13	0.12
Additional Paid-in Capital	1,247	1,240	1,190	1,150	1,083	-
Accumulated Other Comprehensive Income	-35.37	-28.08	-33.76	-36.26	-54.67	-
Retained Earnings	-818.3	-831.28	-795.76	-744.67	-689.39	-650.84
Shareholders' Equity	393.67	381.03	360.72	368.84	338.9	231.93
Total Liabilities & Equity	1,072	1,067	1,010	597	526.76	408
Total Debt	435.68	436.69	432.72	85.01	81.45	86.31
Net Cash (Debt)	409.21	427.47	387.65	357.62	321.02	235.31
Net Cash Growth	-4.27%	10.27%	8.40%	11.40%	36.42%	161.46%
Net Cash Per Share	8.02	8.49	7.75	7.32	7.02	5.54
Book Value	393.67	381.03	360.72	368.84	338.9	231.93
Book Value Per Share	7.72	7.57	7.22	7.54	7.41	5.46
Tangible Book Value	393.67	381.03	360.72	368.84	338.9	231.93
Tangible Book Value Per Share	7.72	7.57	7.22	7.54	7.41	5.46

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q